Jay M. Moyes, Chief Financial Officer at MYRIAD GENETICS INC (MYGN), sold 8,156 shares at $30.00 ($245K) on 2006-11-20, disclosed to the SEC on 2006-11-20.
Scheduled sale ($245k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 3,023 | $91K | 37.1% |
| 2 | $30.00 | 333 | $10K | 4.1% |
| 3 | $30.00 | 4,800 | $144K | 58.9% |
| Total | $30.00 avg | 8,156 | $245K | 100% |
| Filing → |
| SINT | BUY | 2025-08-27 | $11K | — | Filing → |
| PBYI | SELL | 2025-06-17 | $75K | — | Filing → |
| PBYI | SELL | 2024-06-17 | $73K | — | Filing → |